Home/Filings/4/0000899243-23-000619
4//SEC Filing

Ros Matthew 4

Accession 0000899243-23-000619

CIK 0001622229other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 4:31 PM ET

Size

5.8 KB

Accession

0000899243-23-000619

Insider Transaction Report

Form 4
Period: 2023-01-03
Ros Matthew
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-01-03$7.19/sh+1,792$12,8761,792 total
    Exercise: $11.07From: 2023-01-03Exp: 2033-01-03Common Stock (1,792 underlying)
Footnotes (1)
  • [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.

Issuer

Cogent Biosciences, Inc.

CIK 0001622229

Entity typeother

Related Parties

1
  • filerCIK 0001673802

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:31 PM ET
Size
5.8 KB